YOLFTbeta
Mabion S.A.

Mabion S.A.

MAB · WAR · Healthcare / Biotechnology

10.12PLN+0.02 (+0.20%)

Price History

Full chart

Market Stats

Previous Close10.10
Open10.40
Day Range9.94 – 11.22
52-Week Range6.70 – 10.00
Volume742.70K
Market Cap126.87M
P/E (TTM)0.00
Forward P/E0.00
EPS-3.50
Dividend Yield0.00%
Beta0.38
50-Day Avg7.70
200-Day Avg7.86

About

Mabion S.A., a biopharmaceutical company, provides contract development, analytics, and manufacturing services for biologics in Poland. It offers drug substance manufacturing, process development, analytics, and cell line development services. The company also provides medicines for cancer, autoimmune diseases, rare diseases, and other diseases. The company was founded in 2007 and is headquartered in Konstantynów Lódzki, Poland.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Krzysztof Robert Kaczmarczyk
  • Employees199
  • HeadquartersMedical Biotechnology Scientific and Industrial Complex, Konstantynów Lódzki, Poland, 95-050, Poland
  • Websitehttps://www.mabion.eu

Leadership

  • Mr. Krzysztof Robert KaczmarczykCEO & President of Management Board · b. 1977
  • Ms. Julita Balcerek M.D.Member of the Management Board, Operations Director & COO
  • Mr. Adam PietruszkiewiczChief Commercial Officer, Business Development Director & Member of Management Board
  • Pawel PobiedzinskiHead of Logistics & Procurement
  • Ms. Joanna KrolasikHead of Microbiology Division
  • Paulina TobolaHead of Analytics Development Department

Financials

Income Statement

Currency: PLN2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue-1.53M985.38K884.78K5.80K829.70K2.73M--001.59M56.87M163.98M151.68M69.02M15.76M
Growth (%)---35.49%-10.21%-99.34%+14205.17%+229.40%-----+3476.92%+188.33%-7.50%-54.50%-77.17%
Cost of Revenue5.98K-1.18M-7.00M1.84M6.00K4.22M5.64M758.00K971.00K797.00K466.00K9.83M20.99M98.00M37.09M27.87M33.17M
Gross Profit-5.98K2.70M7.99M-956.22K-200-3.39M-2.90M-758.00K-971.00K-797.00K-466.00K-9.83M28.18M65.99M114.58M41.15M-17.41M
Gross Margin-177.05%810.76%-108.07%-3.45%-408.74%-106.29%-----618.18%49.55%40.24%75.54%59.62%-110.52%
Operating Expense383.80K2.33M9.86M1.41M4.01M1.20M1.18M54.77M61.41M63.83M62.81M46.55M39.14M37.77M59.52M48.73M35.34M
Operating Income-389.78K376.94K-1.87M-2.36M-4.01M-4.59M-4.08M-55.53M-62.38M-64.63M-63.27M-56.37M-10.96M28.21M55.06M-7.57M-52.76M
Operating Margin-24.68%-189.54%-267.14%-69089.66%-553.07%-149.29%-----3545.53%-19.28%17.21%36.30%-10.97%-334.83%
EBITDA-357.40K460.35K-544.52K884.80K5.80K830.00K-37.65M-48.66M-47.90M-55.76M-51.79M-44.27M118.00K29.63M58.31M10.20M-43.66M
EBITDA Margin-30.14%-55.26%100.00%100.00%100.04%-1377.50%-----2784.53%0.21%18.07%38.45%14.78%-277.11%
Net Income-328.75K471.45K-1.35M-2.12M-3.89M-4.46M-4.60M-55.83M-57.89M-68.87M-64.71M-57.19M1.90M23.19M41.27M-6.33M-62.61M
Net Income Margin-30.86%-137.41%-239.77%-67089.66%-537.69%-168.20%-----3596.73%3.35%14.14%27.21%-9.18%-397.37%
R&D------37.50M44.22M43.26M44.93M40.71M35.73M13.60M15.12M6.25M902.00K75.00K
R&D as % of Total Revenue------1371.97%----2246.92%23.92%9.22%4.12%1.31%0.48%
Interest Expense-2.72K77.25K---235.00K217.00K1.72M1.92M751.00K1.41M1.53M1.94M1.22M3.15M804.00K
Interest Expense % of Total Revenue-0.18%7.84%---8.60%----88.55%2.68%1.18%0.80%4.56%5.10%

Balance Sheet

Currency: PLN2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets348.15K23.44M26.94M3.97B754.68M1.48B193.55M91.25M82.44M144.72M113.55M78.32M184.24M186.18M208.25M159.47M110.43M
Total Liabilities422.95K1.72M6.58M2.14B234.13M483.33M65.91M87.52M136.60M102.58M135.13M155.71M130.92M109.67M90.48M48.03M55.08M
Total Equity-74.80K21.72M20.37M1.82B520.55M997.84M127.64M3.73M-54.16M42.14M-21.58M-77.39M53.31M76.51M117.78M111.44M48.83M
Cash5.10K17.47M8.23M4.50M3.61M6.95M6.07M14.83M1.04M58.42M27.97M2.40M48.71M53.64M47.82M38.45M6.37M
Total Debt-----96.00K232.00K12.72M66.03M5.64M21.94M36.68M20.36M7.28M35.83M4.61M12.69M
Net Debt-5.10K-17.47M-8.23M-4.50M-3.61M-6.86M-5.84M-2.11M64.99M-52.78M-6.03M34.29M-28.34M-46.36M-11.99M-33.84M6.32M

Cash Flow

Currency: PLN2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-298.41K-1.40M-11.74M-13.51M-27.59M-24.39M-33.97M-15.22M-54.13M-38.94M-33.76M-35.24M-32.91M38.84M-2.33M39.86M-41.59M
Investing Cash Flow-25.58K-2.33M-3.50M-3.05M-10.98M-44.35M-12.63M-2.49M-7.11M-6.77M-9.16M-3.00M-31.28M-16.06M-37.98M-12.29M-795.00K
Financing Cash Flow291.71K21.19M6.00M12.83M37.67M-750.00K45.72M26.46M47.45M103.09M12.47M12.67M110.50M-17.84M34.49M-36.95M10.31M
Capital Expenditure25.58K2.33M3.50M2.95M10.05M39.86M12.63M2.49M7.03M6.85M9.21M3.36M31.61M16.73M38.00M12.33M892.00K
Free Cash Flow-323.99K-3.73M-15.24M-16.46M-37.64M-64.24M-46.60M-17.71M-61.16M-45.79M-42.97M-38.60M-64.53M22.11M-40.33M26.28M-42.48M
FCF to OCF108.57%266.18%129.83%121.81%136.42%263.44%137.17%116.37%112.98%117.59%127.29%109.54%196.07%56.92%1728.68%65.94%102.14%

Earnings

Report DateMar 31, 2012Jun 30, 2012Sep 30, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Mar 21, 2016May 12, 2016Aug 31, 2016Nov 16, 2016Dec 31, 2016Apr 26, 2017Sep 18, 2017Nov 30, 2017Dec 31, 2017Apr 27, 2018Sep 14, 2018Nov 15, 2018Dec 31, 2018May 16, 2019Sep 12, 2019Nov 14, 2019Dec 31, 2019Apr 8, 2020Sep 22, 2020Nov 23, 2020Dec 31, 2020May 20, 2021Sep 16, 2021Nov 29, 2021Dec 31, 2021May 27, 2022Sep 30, 2022Nov 24, 2022Dec 31, 2022Apr 22, 2023Sep 12, 2023Nov 14, 2023Dec 31, 2023May 14, 2024Sep 10, 2024Nov 5, 2024Dec 31, 2024May 27, 2025Sep 9, 2025Sep 30, 2025Dec 31, 2025May 25, 2026Jun 30, 2026
EPS Estimate---------------------------------------------------------
EPS Actual-0.04-0.07-0.04-0.06-0.16-0.11-0.15-0.09-0.11-0.13-0.14-0.15-0.05-0.22-0.02-0.19-0.22-0.16-4.18-1.09-1.06-1.12-1.63-1.22-2.05-0.81-1.21-1.09-1.22-1.22-1.11-1.12-0.80-0.66-1.15-1.24-0.15-0.972.300.460.32-0.310.971.020.940.67-0.081.090.64-1.01-1.11-0.94-0.95-0.67-1.31-0.60-0.92
Surprise---------------------------------------------------------
Timing--------------Pre-marketPre-marketAfter-hoursPre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursPre-marketAfter-hours-Pre-market-After-hours-Pre-marketPre-marketPre-market-Pre-marketPre-marketAfter-hours-Pre-marketPre-market--Pre-market-

Key Statistics & Ratios

Market Cap126.87M
Enterprise Value153.36M
Trailing P/E0.00
Forward P/E0.00
Price / Sales7.20
Price / Book5.25
EPS-3.50
Book Value1.49
Revenue (TTM)17.61M
Gross Profit (TTM)-8.91M
EBITDA-29.57M
Profit Margin0.00%
Operating Margin-180.11%
Return on Equity-107.92%
Return on Assets-20.67%
Shares Outstanding16.16M
Shares Float11.48M
Beta0.38
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%